Scientific depth across the diseases that matter most.
Our medical and operational teams bring deep therapeutic expertise to every protocol — ensuring trials are grounded in clinical reality and regulatory precedent.
Oncology
Solid tumors, hematology, immuno-oncology, cell & gene therapy, biomarker-driven trials.
Cardiology
Heart failure, lipid disorders, anticoagulation, structural heart and prevention studies.
Neurology
Alzheimer's, Parkinson's, multiple sclerosis (MS), epilepsy, rare neurological disorders and neuropsychiatry.
Infectious Diseases
Antivirals, antimicrobials, vaccines, hospital-acquired infections and pandemic response.
Endocrinology & Metabolism
Diabetes, obesity, thyroid, NASH, rare endocrine disorders.
Rare Diseases
Small-population studies, natural history, biomarker discovery and patient registries.
Ophthalmology
Retinal disease, glaucoma, dry eye, gene therapy for inherited retinal disorders.
Musculoskeletal
Osteoporosis, arthritis, regenerative medicine and orthopedic devices.
Partner with us to accelerate your drug development journey
From first-in-human trials to commercialization, our experts deliver the science, speed, and certainty pharma teams trust.